2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
L

2020 ASCO Updates on Relapsed DLBCL: Is Auto-HCT Beneficial in PET/CT+ Disease?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Luis Fayad
By 2020 ASCO Virtual Direct™ Highlights FEATURING Luis Fayad
5 views
October 12, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou
Hematologic Oncology
05:34
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on Relapsed DLBCL: Is Auto-HCT Beneficial in PET/C…

Feat. L. Fayad
07:11
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on R/R iNHL: Does Axi-Cel Combination Offer Promis…

Feat. L. Fayad
05:18
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Previously Untreated CLL: Does Time-Limited …

Feat. L. Fayad
06:14
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on R/R cHL: Does Pembro Show Any PFS Improvement C…

Feat. L. Fayad
06:09
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Aggressive B-Cell Lymphomas: Can Venetoclax …

Feat. L. Fayad